BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38465349)

  • 1. Subfoveal Choroidal Neovascular Membrane Secondary to Idiopathic Intracranial Hypertension.
    Pereira A; Nichani PAH; Yan P; Micieli JA
    J Vitreoretin Dis; 2024; 8(2):192-195. PubMed ID: 38465349
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
    Narayanan R; Shah VA
    Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choroidal osteoma with CNVM - Successful treatment with intravitreal Bevacizumab.
    Ayachit GS; Pandey N; Dwivedi V
    Saudi J Ophthalmol; 2011 Apr; 25(2):199-202. PubMed ID: 23960923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
    Ozgonul C; Moinuddin O; Munie M; Lee MS; Bhatti MT; Landau K; Van Stavern GP; Mackay DD; Lebas M; DeLott LB; Cornblath WT; Besirli CG
    J Neuroophthalmol; 2019 Dec; 39(4):451-457. PubMed ID: 30951011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab.
    Pandey N; Guruprasad A
    Clin Ophthalmol; 2010 Oct; 4():1081-4. PubMed ID: 20957052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
    Lee IJ; Maccheron LJ; Kwan AS
    J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor.
    Mathur G; George AE; Sen P
    Oman J Ophthalmol; 2014 Sep; 7(3):141-3. PubMed ID: 25378880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Choroidal Neovascular Membranes Associated with Choroidal Nevi.
    Munie MT; Demirci H
    Ophthalmol Retina; 2018 Jan; 2(1):53-58. PubMed ID: 31047303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Choroidal Neovascular Membrane as the Initial Presentation of
    Babu K; Padmapriya PG; Gowda SMN; Murthy PR
    Ocul Immunol Inflamm; 2024 Jun; ():1-6. PubMed ID: 38889671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization due to Sorsby macular dystrophy.
    Kapoor KG; Bakri SJ
    J Ocul Pharmacol Ther; 2013 May; 29(4):444-7. PubMed ID: 23581613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral nonsimultaneous visual loss associated with idiopathic arterial pulmonary hypertension.
    Nehemy MB; Torquetti L; Vasconcelos-Santos DV
    Retin Cases Brief Rep; 2010; 4(2):154-7. PubMed ID: 25390391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable clinical outcome with intravitreal aflibercept treatment in a case with bilateral choroidal neovascular membrane and quiescent Vogt-Koyanagi-Harada syndrome.
    Ipek SC; Ayhan Z; Emre S; Saatci AO
    GMS Ophthalmol Cases; 2020; 10():Doc23. PubMed ID: 32676268
    [No Abstract]   [Full Text] [Related]  

  • 15. Optical coherence tomography angiography-guided diagnosis of a traumatic choroidal rupture-associated choroidal neovasular membrane and its management with intravitreal ranibizumab.
    Saraswat NK; Samanta R; Puthalath AS; Luthra S; Sood G; Mittal SK
    Taiwan J Ophthalmol; 2021; 11(3):300-304. PubMed ID: 34703748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic choroidal neovascular membrane in a young female.
    Waheeb SA; Showail MJ
    Oman J Ophthalmol; 2009 Sep; 2(3):133-6. PubMed ID: 20927211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory choroidal neovascular membrane after healed tuberculous choroidal granuloma.
    Lodhi SA; Saifuddin K; Devulapally S
    GMS Ophthalmol Cases; 2017; 7():Doc06. PubMed ID: 28293535
    [No Abstract]   [Full Text] [Related]  

  • 18. Anterior ischemic optic neuropathy in a patient with papilledema from idiopathic intracranial hypertension.
    Ma J; Micieli JA
    Am J Ophthalmol Case Rep; 2020 Mar; 17():100593. PubMed ID: 31956730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
    Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
    Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal neovascular membrane in paediatric patients: clinical characteristics and outcomes.
    Padhi TR; Anderson BJ; Abbey AM; Yonekawa Y; Stem M; Alam D; Modi RR; Savla LP; Trese MT; Capone A; Drenser KA; Besirli CG
    Br J Ophthalmol; 2018 Sep; 102(9):1232-1237. PubMed ID: 29217515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.